@mmohammed39
Living in Maiduguri 🌍 | Fintech Professional | Love Church & Comedy
USC researchers say a plasma-based screening tool reduced scans that ended in ineligibility from 71% to 31% during recruitment for the AHEAD 3-45 trial.
